Christopher W. McAleer
University of Central Florida
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christopher W. McAleer.
Journal of Biotechnology | 2014
Alec S.T. Smith; Christopher J. Long; K. Pirozzi; Sarah Najjar; Christopher W. McAleer; H.H. Vandenburgh; James J. Hickman
This report details the development of a non-invasive in vitro assay system for investigating the functional maturation and performance of human skeletal myotubes. Data is presented demonstrating the survival and differentiation of human myotubes on microscale silicon cantilevers in a defined, serum-free system. These cultures can be stimulated electrically and the resulting contraction quantified using modified atomic force microscopy technology. This system provides a higher degree of sensitivity for investigating contractile waveforms than video-based analysis, and represents the first system capable of measuring the contractile activity of individual human muscle myotubes in a reliable, high-throughput and non-invasive manner. The development of such a technique is critical for the advancement of body-on-a-chip platforms toward application in pre-clinical drug development screens.
Experimental Biology and Medicine | 2017
Ying I. Wang; Carlota Oleaga; Christopher J. Long; Mandy B. Esch; Christopher W. McAleer; Paula G. Miller; James J. Hickman; Michael L. Shuler
Integrated multi-organ microphysiological systems are an evolving tool for preclinical evaluation of the potential toxicity and efficacy of drug candidates. Such systems, also known as Body-on-a-Chip devices, have a great potential to increase the successful conversion of drug candidates entering clinical trials into approved drugs. Systems, to be attractive for commercial adoption, need to be inexpensive, easy to operate, and give reproducible results. Further, the ability to measure functional responses, such as electrical activity, force generation, and barrier integrity of organ surrogates, enhances the ability to monitor response to drugs. The ability to operate a system for significant periods of time (up to 28 d) will provide potential to estimate chronic as well as acute responses of the human body. Here we review progress towards a self-contained low-cost microphysiological system with functional measurements of physiological responses. Impact statement Multi-organ microphysiological systems are promising devices to improve the drug development process. The development of a pumpless system represents the ability to build multi-organ systems that are of low cost, high reliability, and self-contained. These features, coupled with the ability to measure electrical and mechanical response in addition to chemical or metabolic changes, provides an attractive system for incorporation into the drug development process. This will be the most complete review of the pumpless platform with recirculation yet written.
Journal of Applied Physiology | 2014
Christopher W. McAleer; Alec S.T. Smith; Sarah Najjar; Kristen Pirozzi; Christopher J. Long; James J. Hickman
The ability to accurately measure skeletal muscle functional performance at the single-cell level would be advantageous for exercise physiology studies and disease modeling applications. To that end, this study characterizes the functional response of individual skeletal muscle myotubes derived from adult rodent tissue to creatine treatment and chronic exercise. The observed improvements to functional performance in response to these treatments appear to correlate with alterations in hypertrophic and mitochondrial biogenesis pathways, supporting previously published in vivo and in vitro data, which highlights the role of these pathways in augmenting skeletal muscle output. The developed system represents a multiplexed functional in vitro assay capable of long-term assessment of contractile cellular outputs in real-time that is compatible with concomitant molecular biology analysis. Adoption of this system in drug toxicity and efficacy studies would improve understanding of compound activity on physical cellular outputs and provide more streamlined and predictive data for future preclinical analyses.
Biotechnology Progress | 2015
Christopher W. McAleer; John W. Rumsey; Maria Stancescu; James J. Hickman
This manuscript describes the development of a culture system whereby mature contracting myotubes were formed from adult rat derived satellite cells. Satellite cells, extracted from the Tibialis Anterior of adult rats, were grown in defined serum‐free growth and differentiation media, on a nonbiological substrate, N‐1[3‐trimethoxysilyl propyl] diethylenetriamine. Myotubes were evaluated morphologically and immunocytochemically, using MyHC specific antibodies, as well as functionally using patch clamp electrophysiology to measure ion channel activity. Results indicated the establishment of the rapid expression of adult myosin isoforms that contrasts to their slow development in embryonic cultures. This culture system has applications in the understanding and treatment of age‐related muscle myopathy, muscular dystrophy, and for skeletal muscle engineering by providing a more relevant phenotype for both in vitro and in vivo applications.
In Vitro Cellular & Developmental Biology – Animal | 2013
John W. Rumsey; Christopher W. McAleer; Mainak Das; Abhijeet Bhalkikar; Kerry Wilson; Maria Stancescu; Stephen Lambert; James J. Hickman
One of the most important developmental modifications of the nervous system is Schwann cell myelination of axons. Schwann cells ensheath axons to create myelin segments to provide protection to the axon as well as increase the conduction of action potentials. In vitro neuronal systems provide a unique modality to study a variety of factors influencing myelination as well as diseases associated with myelin sheath degradation. This work details the development of a patterned in vitro myelinating dorsal root ganglion culture. This defined system utilized a serum-free medium in combination with a patterned substrate, utilizing the cytophobic and cytophilic molecules (poly)ethylene glycol (PEG) and N-1[3 (trimethoxysilyl) propyl] diethylenetriamine (DETA), respectively. Directional outgrowth of the neurites and subsequent myelination was controlled by surface modifications, and conformity to the pattern was measured over the duration of the experiments. The myelinated segments and nodal proteins were visualized and quantified using confocal microscopy. This tissue-engineered system provides a highly controlled, reproducible model for studying Schwann cell interactions with sensory neurons, as well as the myelination process, and its effect on neuronal plasticity and peripheral nerve regeneration. It is also compatible for use in bio-hybrid constructs to reproduce the stretch reflex arc on a chip because the media combination used is the same that we have used previously for motoneurons, muscle, and for neuromuscular junction (NMJ) formation. This work could have application for the study of demyelinating diseases such as diabetes induced peripheral neuropathy and could rapidly translate to a role in the discovery of drugs promoting enhanced peripheral nervous system (PNS) remyelination.
Journal of Visualized Experiments | 2014
Alec S.T. Smith; Christopher J. Long; Christopher W. McAleer; Nathaniel Bobbitt; Balaji Srinivasan; James J. Hickman
The development of more predictive and biologically relevant in vitro assays is predicated on the advancement of versatile cell culture systems which facilitate the functional assessment of the seeded cells. To that end, microscale cantilever technology offers a platform with which to measure the contractile functionality of a range of cell types, including skeletal, cardiac, and smooth muscle cells, through assessment of contraction induced substrate bending. Application of multiplexed cantilever arrays provides the means to develop moderate to high-throughput protocols for assessing drug efficacy and toxicity, disease phenotype and progression, as well as neuromuscular and other cell-cell interactions. This manuscript provides the details for fabricating reliable cantilever arrays for this purpose, and the methods required to successfully culture cells on these surfaces. Further description is provided on the steps necessary to perform functional analysis of contractile cell types maintained on such arrays using a novel laser and photo-detector system. The representative data provided highlights the precision and reproducible nature of the analysis of contractile function possible using this system, as well as the wide range of studies to which such technology can be applied. Successful widespread adoption of this system could provide investigators with the means to perform rapid, low cost functional studies in vitro, leading to more accurate predictions of tissue performance, disease development and response to novel therapeutic treatment.
Biomaterials | 2018
Carlota Oleaga; Anne Riu; Sandra Rothemund; Andrea Lavado; Christopher W. McAleer; Christopher J. Long; Keisha Persaud; Narasimhan Sriram Narasimhan; My Tran; Jeffry Roles; Carlos A. Carmona-Moran; Trevor Sasserath; Daniel H. Elbrecht; Lee Kumanchik; L. Richard Bridges; Candace Martin; Mark T. Schnepper; Gail Ekman; Max Jackson; Ying I. Wang; Jessica Langer; Silvia Teissier; James J. Hickman
Regulation of cosmetic testing and poor predictivity of preclinical drug studies has spurred efforts to develop new methods for systemic toxicity. Current in vitro assays do not fully represent physiology, often lacking xenobiotic metabolism. Functional human multi-organ systems containing iPSC derived cardiomyocytes and primary hepatocytes were maintained under flow using a low-volume pumpless system in a serum-free medium. The functional readouts for contractile force and electrical conductivity enabled the non-invasive study of cardiac function. The presence of the hepatocytes in the system induced cardiotoxic effects from cyclophosphamide and reduced them for terfenadine due to drug metabolism, as expected from each compounds pharmacology. A computational fluid dynamics simulation enabled the prediction of terfenadine-fexofenadine pharmacokinetics, which was validated by HPLC-MS. This in vitro platform recapitulates primary aspects of the in vivo crosstalk between heart and liver and enables pharmacological studies, involving both organs in a single in vitro platform. The system enables non-invasive readouts of cardiotoxicity of drugs and their metabolites. Hepatotoxicity can also be evaluated by biomarker analysis and change in metabolic function. Integration of metabolic function in toxicology models can improve adverse effects prediction in preclinical studies and this system could also be used for chronic studies as well.
Archive | 2016
Xiufang Guo; Frank Sommerhage; Christopher W. McAleer; Candace Martin; Christopher J. Long; Ying Wang; Navaneetha Santhanam; Alisha Colon; Carlota Oleaga Sancho; James J. Hickman
Neural models are invaluable for understanding the physiology and pathology of the nervous system as well as for developing therapeutic strategies targeting relevant injury and diseases. New developments in the field of stem cells enable great feasibility and potential for generating in vitro models of the nervous system, especially human-based models to study diseases and for drug screening. The reflex arc has been a popular model system for studying neural regulation and circuit modulation. Numerous in vitro models of this system have been generated, among which modeling of the efferent portion of the reflex arc, the connection between motoneurons and skeletal muscles, or the neuromuscular junction (NMJ), has been the central focus. To a lesser extent, the afferent portion, or intrafusal fiber to sensory neuron segment, has also been studied as well as the sensory neuron to motoneuron connections. Furthermore, the integration of interdisciplinary technologies such as surface patterning, microelectrode arrays, and cantilever systems is driving biological NMJ systems more toward in vitro platforms for high content and high throughput capabilities which are suitable for drug screening. To better mimic the in vivo condition, inclusions of other components are also in progress, such as the blood–brain barrier, Bio-MEMs technologies and multi-organ-on-a-chip systems. The concurrent progress in integration of biology and engineering will accelerate the development of these in vitro nervous system models which have an increasing suitability for studying physiology and pathology of the human nervous system as well as for use in drug discovery research.
Stem Cell Research & Therapy | 2013
Alec S.T. Smith; Christopher J. Long; Bonnie J. Berry; Christopher W. McAleer; Maria Stancescu; Peter Molnar; Paula G. Miller; Mandy B. Esch; Jean-Matthieu Prot; James J. Hickman; Michael L. Shuler
Biomaterials | 2015
Maria Stancescu; Peter Molnar; Christopher W. McAleer; William McLamb; Christopher J. Long; Carlota Oleaga; Jean-Matthieu Prot; James J. Hickman